Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00552045 · ClinicalTrials.gov registry record
Epilepsy Phenome/Genome Project
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 4,150
- Enrollment target
NCT00552045: Completed study, sponsored by University of California, San Francisco.
NCT00552045 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 4,150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00552045 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 4,150 participants
- Enrollment target
Study Summary
The purpose of this study is to collect detailed information about the characteristics and genetics of a large number of individuals with epilepsy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,150 participants |
| Start Date | 2007-11 |
| Est. Completion | 2018-10 |
What the finished NCT00552045 record still lists
NCT00552045 is an observational study that tracks outcomes without assigning an intervention. Its 4,150 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00552045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00552045 about?
NCT00552045 is a clinical study titled "Epilepsy Phenome/Genome Project". The purpose of this study is to collect detailed information about the characteristics and genetics of a large number of individuals with epilepsy.
What is the current status of trial NCT00552045?
This trial is currently completed. The enrollment target is 4,150 participants. The study started on 2007-11. Estimated completion is 2018-10.
Who is sponsoring clinical trial NCT00552045?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia